Question

A 64-year-old with type 2 diabetes and prior MI is on metformin with A1C 7.8%. eGFR is 65 mL/min/1.73 m². Which agent should be added for cardiovascular risk reduction, independent of baseline A1C?

Accepted Answer

GLP-1 receptor agonist with proven CV benefit

Answer

DPP-4 inhibitor

Answer

Thiazolidinedione

Answer

Sulfonylurea

Answer

Basal insulin

Practice question

A 64-year-old with type 2 diabetes and prior MI is on metformin with A1C 7.8%. eGFR is 65 mL/min/1.73 m². Which agent should be added for cardiovascular risk reduction, independent of baseline A1C?